Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
505.00    4.50 (0.90%)
Bid:
505.00
Ask:
505.50
Spread: 0.50 (0.099%)
Market Cap: £2.23b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Director/PDMR Shareholding

8 Dec 2022 13:00

RNS Number : 0647J
Tate & Lyle PLC
08 December 2022
 

Tate & Lyle PLC

 

Notification of transactions by Persons Discharging Managerial Responsibilities

Tate & Lyle PLC (the 'Company') announces that on 7 December 2022 the following Persons Discharging Managerial Responsibilities ('PDMR') were granted options to purchase ordinary shares of 29 1/6p each in the capital of the Company ('Shares') under the Tate & Lyle Sharesave Plan 2020 at an exercise price of 571 pence per Share:

 

Name

No. of Sharessubject to option

Exercisable period

Dawn Allen

5,253

1 March 2028 - 31 August 2028

Lindsay Beardsell

315

1 March 2026 - 31 August 2026

Victoria Spadaro-Grant

5,253

1 March 2028 - 31 August 2028

 

 

The notification below, which has been made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.

 

Claire-Marie O'Grady

Company Secretary

8 December 2022

 

 

 

 

 

 

Notification and public disclosure of transactions by person discharging managerial responsibilities and persons closely associated with them

 

Details of PDMR / person closely associated with them ('PCA')

a)

Name

Dawn Allen

2.

Reason for the notification

a)

Position / status

Chief Financial Officer

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tate & Lyle PLC

b)

LEI

2138008K14474WPKZ244

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary shares of 29 1/6 pence each in the capital of Tate & Lyle PLC

 

GB00BP92CJ43

b)

Nature of the transaction

Grant of a 5-year option over shares with an exercise price of 571 pence per share under the Tate & Lyle Sharesave Plan 2020

c)

Price(s) and volume(s)

Price(s)

Volume(s)

GBP 5.71

5,253

d)

Aggregated information

- Aggregated volume

- Price

 

 

5,253

 

GBP 29,994.63

e)

Date of the transaction

2022-12-07

f)

Place of the transaction

Outside a trading venue

 

 

Details of PDMR / person closely associated with them ('PCA')

a)

Name

Lindsay Beardsell

2.

Reason for the notification

a)

Position / status

Executive VP, General Counsel

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tate & Lyle PLC

b)

LEI

2138008K14474WPKZ244

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary shares of 29 1/6 pence each in the capital of Tate & Lyle PLC

 

GB00BP92CJ43

b)

Nature of the transaction

Grant of a 3-year option over shares with an exercise price of 571 pence per share under the Tate & Lyle Sharesave Plan 2020

c)

Price(s) and volume(s)

Price(s)

Volume(s)

GBP 5.71

315

d)

Aggregated information

- Aggregated volume

- Price

 

 

315

 

GBP 1,798.65

e)

Date of the transaction

2022-12-07

f)

Place of the transaction

Outside a trading venue

 

Details of PDMR / person closely associated with them ('PCA')

a)

Name

Victoria Spadaro-Grant

2.

Reason for the notification

a)

Position / status

President, Innovation and Commercial Development

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tate & Lyle PLC

b)

LEI

2138008K14474WPKZ244

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary shares of 29 1/6 pence each in the capital of Tate & Lyle PLC

 

GB00BP92CJ43

b)

Nature of the transaction

Grant of a 5-year option over shares with an exercise price of 571 pence per share under the Tate & Lyle Sharesave Plan 2020

c)

Price(s) and volume(s)

Price(s)

Volume(s)

GBP 5.71

5,253

d)

Aggregated information

- Aggregated volume

- Price

 

 

5,253

 

GBP 29,994.63

e)

Date of the transaction

2022-12-07

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUWOKRUOUURRA
Date   Source Headline
21st May 202612:15 pmRNSForm 8.3 - Tate & Lyle plc
21st May 202612:06 pmBUSForm 8.3 - Tate & Lyle
21st May 202611:53 amRNSForm 8.5 (EPT/RI) - Tate & Lyle PLC
21st May 202611:22 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
21st May 202611:13 amRNS20260520_TATE & LYLE_8.5 EPT NON-RI_UK_BOFASE
21st May 202611:11 amRNS20260520_TATE & LYLE_8.5 EPT RI_UK_MLI
21st May 202611:09 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
21st May 202611:01 amRNSForm 8.3 TATE & LYLE PLC
21st May 202610:28 amRNSForm 8.3 - Tate & Lyle Plc
21st May 20268:29 amRNSForm 8.5 (EPT/RI)
21st May 20267:00 amRNSFinal Results
20th May 20264:28 pmRNSForm 8.5 - Tate & Lyle Plc
20th May 20264:26 pmRNSForm 8.5 (EPT/RI)-Tate & Lyle plc Amend
20th May 20263:27 pmRNSForm 8.3 Tate & Lyle plc
20th May 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
20th May 20262:49 pmRNSForm 8.3 - Tate & Lyle plc
20th May 20262:03 pmEQSForm 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
20th May 20261:52 pmRNSForm 8.3 - Tate & Lyle plc
20th May 20261:28 pmRNSForm 8.3 - Tate & Lyle plc
20th May 20261:22 pmRNSForm 8.3 TATE & LYLE PLC
20th May 202612:26 pmRNSForm 8.3 Tate & Lyle Plc
20th May 202612:05 pmRNSForm 8.3 - Tate & Lyle plc
20th May 202611:59 amRNSForm 8.5 (EPT/NON-RI) - Tate & Lyle PLC
20th May 202611:58 amRNSForm 8.5 (EPT/RI) - Tate & Lyle PLC
20th May 202611:47 amRNSForm 8.3- TATE & LYLZ
20th May 202611:35 amRNS20260519_TATE & LYLE_8.5 EPT RI_UK_MLI
20th May 202611:15 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle Plc
20th May 202611:02 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
20th May 20269:21 amRNSForm 8.5 (EPT/RI)
20th May 20269:18 amRNSForm 8.3 - Tate and Lyle PLC
20th May 20267:33 amRNSForm 8.5 (EPT/RI) - Amend - Tate & Lyle PLC
19th May 20265:59 pmRNSForm 8.5 (EPT/RI)-Tate & Lyle plc Amend
19th May 20265:51 pmRNSForm 8.3 - Tate & Lyle PLC
19th May 20263:39 pmRNSForm 8.3 TATE & LYLE PLC
19th May 20263:25 pmRNSForm 8.3 - Tate & Lyle PLC
19th May 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
19th May 20262:08 pmRNSForm 8.3 - Tate & Lyle plc
19th May 20262:00 pmEQSForm 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
19th May 202611:53 amRNSForm 8.5 (EPT/NON-RI) - Tate & Lyle PLC
19th May 202611:52 amRNSForm 8.5 (EPT/RI) - Tate & Lyle PLC
19th May 202611:15 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
19th May 202611:08 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
19th May 202611:06 amRNSForm 8.3 Tate & Lyle
19th May 202611:05 amRNSForm 8.3 - Tate & Lyle plc
19th May 202610:53 amBUSForm 8.3 - Tate & Lyle plc
19th May 202610:45 amRNSForm 8.3 - Tate & Lyle PLC
19th May 202610:19 amRNS20260518_TATE & LYLE_8.5 EPT RI_UK_MLI
19th May 20269:32 amRNSForm 8.5 (EPT/RI)
18th May 20265:50 pmRNSForm 8.5 (EPT/RI)-Tate & Lyle plc Amend
18th May 20264:48 pmRNS20260514_TATE & LYLE_8.5 EPT RI_UK_MLI_replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.